We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CHL
1776
DELISTED
China Mobile Limited
CHL
| $1.13M | ﹤0.01% |
17,434
+204
| +1% | +$13.3K |
|
1777
Standard Motor Products
SMP
$911M
| $1.13M | ﹤0.01% |
26,815
+2,250
| +9% | +$87.8K |
|
|
STMP
1778
DELISTED
Stamps.com, Inc.
STMP
| $1.13M | ﹤0.01% |
16,831
+2,075
| +14% | +$110K |
|
|
KG
1779
Kestrel Group
KG
$69M
| $1.13M | ﹤0.01% |
3,818
+85
| +2% | +$23.4K |
|
|
CTCT
1780
DELISTED
CONSTANT CONTACT, INC COM
CTCT
| $1.13M | ﹤0.01% |
29,575
+4,400
| +17% | +$173K |
|
1781
Southside Bancshares
SBSI
$967M
| $1.13M | ﹤0.01% |
44,380
+4,746
| +12% | +$120K |
|
1782
Ameris Bancorp
ABCB
$5.89B
| $1.13M | ﹤0.01% |
42,621
+1,200
| +3% | +$30.3K |
|
1783
United Fire Group
UFCS
$1.4B
| $1.12M | ﹤0.01% |
35,358
+1,050
| +3% | +$30.8K |
|
1784
iShares Core S&P 500 ETF
IVV
$902B
| $1.12M | ﹤0.01% |
+5,400
| New | +$1.12M |
|
1785
Zumiez
ZUMZ
$339M
| $1.12M | ﹤0.01% |
27,777
+2,375
| +9% | +$92.1K |
|
1786
SPS Commerce
SPSC
$2.64B
| $1.12M | ﹤0.01% |
33,304
+5,150
| +18% | +$164K |
|
1787
AstraZeneca
AZN
$250B
| $1.11M | ﹤0.01% |
16,230
-1,400
| -8% | -$97.3K |
|
1788
Century Aluminum
CENX
$5.07B
| $1.11M | ﹤0.01% |
80,483
+200
| +0.2% | +$4.03K |
|
|
IPCM
1789
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $1.11M | ﹤0.01% |
23,812
+1,650
| +7% | +$72K |
|
|
STNR
1790
DELISTED
STEINER LEISURE LTD
STNR
| $1.11M | ﹤0.01% |
23,408
-125
| -0.5% | -$5.73K |
|
|
AEGN
1791
DELISTED
Aegion Corp
AEGN
| $1.11M | ﹤0.01% |
61,468
+2,300
| +4% | +$39.3K |
|
|
RJET
1792
DELISTED
REPUBLIC AWYS HLDGS INC
RJET
| $1.11M | ﹤0.01% |
80,627
+10,350
| +15% | +$143K |
|
|
BRLI
1793
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| $1.11M | ﹤0.01% |
31,446
+3,220
| +11% | +$109K |
|
1794
Coty
COTY
$2.48B
| $1.11M | ﹤0.01% |
45,612
+800
| +2% | +$17.2K |
|
|
CSH
1795
DELISTED
CASH AMERICA INTERNATIONAL INC
CSH
| $1.1M | ﹤0.01% |
47,398
+550
| +1% | +$12.2K |
|
1796
Standard BioTools
LAB
$314M
| $1.1M | ﹤0.01% |
26,175
+4,250
| +19% | +$168K |
|
|
NAV
1797
DELISTED
Navistar International
NAV
| $1.1M | ﹤0.01% |
37,291
-1,190
| -3% | -$35.7K |
|
1798
Iridium Communications
IRDM
$5.29B
| $1.1M | ﹤0.01% |
113,133
+13,300
| +13% | +$124K |
|
|
AVIV
1799
DELISTED
AVIV REIT INC COM STK (MD)
AVIV
| $1.1M | ﹤0.01% |
30,101
+425
| +1% | +$15.7K |
|
|
DRII
1800
DELISTED
DIAMOND RESORTS INTL, INC
DRII
| $1.1M | ﹤0.01% |
32,885
+5,315
| +19% | +$167K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.